Core Viewpoint - The company reported a decrease in revenue and profit for the six months ending June 30, 2025, primarily due to a decline in outpatient and inpatient visits, as well as pricing adjustments in response to market competition and national policies [1] Financial Performance - The company achieved revenue of 698 million, a year-on-year decrease of 4.91% [1] - Profit attributable to the parent company was 114 million, reflecting a year-on-year decrease of 16.72% [1] - Basic earnings per share were 0.16 [1] Operational Challenges - The decline in revenue was attributed to a slight decrease in outpatient and inpatient visit numbers, which are primarily focused on basic ophthalmic services [1] - The company plans to implement internal pricing adjustments starting in the second half of 2024 to address increasing market competition and the impact of the national volume-based procurement (VBP) policy [1]
朝聚眼科发布中期业绩，股东应占溢利1.14亿元，同比减少16.72%